We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what can health economics and outcomes researchers gain from leveraging the expertise within the medical publications arena to better communicate the value of their research?
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what they thought were the key motivations for health economics and outcomes researchers working together with medical publications professionals?
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers What type of collaborative initiatives are currently emerging within the medical publications and pharmaceutical arena?
This presentation, which the BMJ’s research editors Domhnall Macauley, Elizabeth Loder and Trish Groves have given at conferences around the world, explains how to get your research published. It includes clear guidelines on how to write a paper, clinical trial registration, ethics, authorship, conflicts of interest and how to navigate the peer review process.
Interview with Dr John Cai, s a highly experienced economist and health economist with 20 years’ experience in both China and the US. John is a Senior Health Policy Analyst at the Massachusetts Executive Office of Health and Human Services in the U.S.
We asked Dr John Cai if the Chinese hospitals 15% mark up encourages use of expensive drugs? If so, how can we change this?
Interview with Dr John Cai, a highly experienced economist and health economist with 20 years’ experience in both China and the US. John is a Senior Health Policy Analyst at the Massachusetts Executive Office of Health and Human Services in the U.S. heor.tv
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked How was ISPOR founded and how much has it changed over the years?
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked about its impact on patient healthcare.
Duncan Dibble and Ruth Whittington speak to Jeff Trotter about observational research and its place in the changing health technology assessment (HTA) environment. heor.tv is a collaboration between http://www.healtheconomicsdigest.com and https://www.rxcomms.com